MoneyWorks4Me

Zydus Lifesciences informs about press release

02 Jun 2025 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated June 2, 2025, titled ‘Zydus receives tentative approval from USFDA for Rifaximin Tablets, 550 mg.’

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..